PHENOMIX SCIENCES, LLC
A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL
A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL is a funding opportunity from PHENOMIX SCIENCES, LLC, up to 348022, closing February 28, 2027.
Feb 28, 2027
(212d left)Overview
NOTE: You must submit in Word format, not PDF, for eRA to update all the systems. Obesity is a chronic, relapsing, and multifactorial disease,[1] with a prevalence of 42%.[2] As with any obesity treatment, the weight loss response with anti-obesity medications (AOMs) is highly variable. For example, semaglutide 2.4…